• Something wrong with this record ?

Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study

A. Pelli, MJ. Junttila, TV. Kenttä, S. Schlögl, M. Zabel, M. Malik, T. Reichlin, R. Willems, MA. Vos, M. Harden, T. Friede, C. Sticherling, HV. Huikuri, EU-CERT-ICD Study Investigators

. 2022 ; 24 (5) : 774-783. [pub] 20220503

Language English Country Great Britain

Document type Controlled Clinical Trial, Journal Article, Multicenter Study

Persistent link   https://www.medvik.cz/link/bmc22018483

Grant support
602299 European Community's 7th Framework Programme FP7/2007-2013

AIM: The association of standard 12-lead electrocardiogram (ECG) markers with benefits of the primary prophylactic implantable cardioverter-defibrillator (ICD) has not been determined in the contemporary era. We analysed traditional and novel ECG variables in a large prospective, controlled primary prophylactic ICD population to assess the predictive value of ECG in terms of ICD benefit. METHODS AND RESULTS: Electrocardiograms from 1477 ICD patients and 700 control patients (EU-CERT-ICD; non-randomized, controlled, prospective multicentre study; ClinicalTrials.gov Identifier: NCT02064192), who met ICD implantation criteria but did not receive the device, were analysed. The primary outcome was all-cause mortality. In ICD patients, the co-primary outcome of first appropriate shock was used. Mean follow-up time was 2.4 ± 1.1 years to death and 2.3 ± 1.2 years to the first appropriate shock. Pathological Q waves were associated with decreased mortality in ICD patients [hazard ratio (HR) 0.54, 95% confidence interval (CI) 0.35-0.84; P < 0.01] and patients with pathological Q waves had significantly more benefit from ICD (HR 0.44, 95% CI 0.21-0.93; P = 0.03). QTc interval increase taken as a continuous variable was associated with both mortality and appropriate shock incidence, but commonly used cut-off values, were not statistically significantly associated with either of the outcomes. CONCLUSION: Pathological Q waves were a strong ECG predictor of ICD benefit in primary prophylactic ICD patients. Excess mortality among Q wave patients seems to be due to arrhythmic death which can be prevented by ICD.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22018483
003      
CZ-PrNML
005      
20220804134810.0
007      
ta
008      
220720s2022 xxk f 000 0|eng||
009      
AR
024    7_
$a 10.1093/europace/euab260 $2 doi
035    __
$a (PubMed)34849744
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxk
100    1_
$a Pelli, Ari $u Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, PO Box 5000, FIN-90014 Oulu, Finland
245    10
$a Q waves are the strongest electrocardiographic variable associated with primary prophylactic implantable cardioverter-defibrillator benefit: a prospective multicentre study / $c A. Pelli, MJ. Junttila, TV. Kenttä, S. Schlögl, M. Zabel, M. Malik, T. Reichlin, R. Willems, MA. Vos, M. Harden, T. Friede, C. Sticherling, HV. Huikuri, EU-CERT-ICD Study Investigators
520    9_
$a AIM: The association of standard 12-lead electrocardiogram (ECG) markers with benefits of the primary prophylactic implantable cardioverter-defibrillator (ICD) has not been determined in the contemporary era. We analysed traditional and novel ECG variables in a large prospective, controlled primary prophylactic ICD population to assess the predictive value of ECG in terms of ICD benefit. METHODS AND RESULTS: Electrocardiograms from 1477 ICD patients and 700 control patients (EU-CERT-ICD; non-randomized, controlled, prospective multicentre study; ClinicalTrials.gov Identifier: NCT02064192), who met ICD implantation criteria but did not receive the device, were analysed. The primary outcome was all-cause mortality. In ICD patients, the co-primary outcome of first appropriate shock was used. Mean follow-up time was 2.4 ± 1.1 years to death and 2.3 ± 1.2 years to the first appropriate shock. Pathological Q waves were associated with decreased mortality in ICD patients [hazard ratio (HR) 0.54, 95% confidence interval (CI) 0.35-0.84; P < 0.01] and patients with pathological Q waves had significantly more benefit from ICD (HR 0.44, 95% CI 0.21-0.93; P = 0.03). QTc interval increase taken as a continuous variable was associated with both mortality and appropriate shock incidence, but commonly used cut-off values, were not statistically significantly associated with either of the outcomes. CONCLUSION: Pathological Q waves were a strong ECG predictor of ICD benefit in primary prophylactic ICD patients. Excess mortality among Q wave patients seems to be due to arrhythmic death which can be prevented by ICD.
650    _2
$a srdeční arytmie $x diagnóza $x etiologie $x terapie $7 D001145
650    _2
$a náhlá srdeční smrt $x epidemiologie $x etiologie $x prevence a kontrola $7 D016757
650    12
$a defibrilátory implantabilní $x škodlivé účinky $7 D017147
650    _2
$a elektrokardiografie $7 D004562
650    _2
$a lidé $7 D006801
650    _2
$a primární prevence $x metody $7 D011322
650    _2
$a prospektivní studie $7 D011446
650    _2
$a rizikové faktory $7 D012307
655    _2
$a klinické zkoušky kontrolované $7 D018848
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
700    1_
$a Junttila, M Juhani $u Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, PO Box 5000, FIN-90014 Oulu, Finland $u Biocenter Oulu, University of Oulu, Oulu, Finland $1 https://orcid.org/0000000288961281
700    1_
$a Kenttä, Tuomas V $u Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, PO Box 5000, FIN-90014 Oulu, Finland
700    1_
$a Schlögl, Simon $u Division of Cardiology, University Medical Center Göttingen Heart Center, Göttingen, Germany
700    1_
$a Zabel, Markus $u Division of Cardiology, University Medical Center Göttingen Heart Center, Göttingen, Germany $u DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany
700    1_
$a Malik, Marek $u National Heart and Lung Institute, Imperial College, London, UK $u Department of Internal Medicine and Cardiology, Masaryk University, Brno, Czech Republic
700    1_
$a Reichlin, Tobias $u Division of Cardiology, University Hospital Basel, Basel, Switzerland $1 https://orcid.org/0000000271978415
700    1_
$a Willems, Rik $u Department of Cardiovascular Sciences, University of Leuven and University Hospitals Leuven, Leuven, Belgium $1 https://orcid.org/0000000254699609
700    1_
$a Vos, Marc A $u Medical Physiology, University Medical Center Utrecht, Utrecht, Netherlands
700    1_
$a Harden, Markus $u Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0000000325339396
700    1_
$a Friede, Tim $u DZHK (German Center for Cardiovascular Research), partner site Göttingen, Göttingen, Germany $u Department of Medical Statistics, University Medical Center Göttingen, Göttingen, Germany $1 https://orcid.org/0000000153477441
700    1_
$a Sticherling, Christian $u Division of Cardiology, University Hospital Basel, Basel, Switzerland $1 https://orcid.org/0000000184287050
700    1_
$a Huikuri, Heikki V $u Research Unit of Internal Medicine, Medical Research Center Oulu, Oulu University Hospital and University of Oulu, PO Box 5000, FIN-90014 Oulu, Finland
710    2_
$a EU-CERT-ICD Study Investigators
773    0_
$w MED00149837 $t Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology $x 1532-2092 $g Roč. 24, č. 5 (2022), s. 774-783
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34849744 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220720 $b ABA008
991    __
$a 20220804134803 $b ABA008
999    __
$a ok $b bmc $g 1822187 $s 1169726
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2022 $b 24 $c 5 $d 774-783 $e 20220503 $i 1532-2092 $m Europace $n Europace $x MED00149837
GRA    __
$a 602299 $p European Community's 7th Framework Programme FP7/2007-2013
LZP    __
$a Pubmed-20220720

Find record

Citation metrics

Archiving options